title: Quantitative Phenotyping of Childhood Leukemia Identifies Variable and Invariable Cell Surface Antigens.
abstract: Cells obtained from 75 cases of childhood leukemia were subjected to flow cytometry analysis to estimate the density of several cell surface antigens and derive a quantitative immunological phenotype. Sixty-five cases of acute lymphoblastic leukemia (ALL) including 10 T-ALL, 6 non-T ALL designated groups I and II (HLA-DRCALLA), 48 non-T ALL termed groups III and IV (HLA-DRCALLA) and one B-ALL were studied; 10 cases of acute myeloblastic leukemia (AML) were also analysed. The estimation of the relative fluorescence index (RFI) on leukemic blasts led to the derivation of mean values for each marker in the leukemia subgroups. We have quantitated the levels of the antigens generally used in the classification of these leukemias (CALLA, CD5, CD20, CD13, HLA-DR and CD19) and of other cell surface antigens associated with leukemic cells. For example, CALLA (CD10) level was high (mean RFI value of 26.4) on the leukemic cells of non-T ALL groups III and IV. The CD5 antigen was present on T-ALL, as expected, with an RFI value of 4.5; however, low levels were observed on the more immature non-T ALL of groups I and II (RFI = 2.3 on only 27% of blast cells). The quantitative analysis of the cell surface antigens associated with non-T ALL has revealed molecules such as CALLA, HLA-DR, CD9 and CD44 present at high and variable levels and others such as CD19, CD38, 44G4, 44D7, 44H9 and 44H6 generally of lower intensity, less variable from one patient to another, and with similar mean levels of expression in the different subgroups. These invariable antigens are not altered by the lineage or stage of differentiation of the leukemic cells. The variable antigens could be correlated with the functional and/or differentiation status of the cells and could also be modified by the alterations of regulatory processes associated with malignancy. The quantitation of multiple leukemia-associated antigens, whose structure and function are becoming rapidly established, should help in elucidating the function of these molecules in leukemogenesis and/or disease progression.
authors.affiliation: a Divisions of Immunology Hospital for Sick Childrenj and Departments of Immunology and Pediatrics, University of Toronto, Toronto, Canada, M5G 1X8.
authors.forename: D
authors.initials: D
authors.lastname: Kreindler
authors.affiliation: a Divisions of Immunology Hospital for Sick Childrenj and Departments of Immunology and Pediatrics, University of Toronto, Toronto, Canada, M5G 1X8.
authors.forename: D
authors.initials: D
authors.lastname: Petsche
authors.affiliation: a Divisions of Immunology Hospital for Sick Childrenj and Departments of Immunology and Pediatrics, University of Toronto, Toronto, Canada, M5G 1X8.
authors.forename: A
authors.initials: A
authors.lastname: Hrincu
authors.affiliation: a Divisions of Immunology Hospital for Sick Childrenj and Departments of Immunology and Pediatrics, University of Toronto, Toronto, Canada, M5G 1X8.
authors.forename: A
authors.initials: A
authors.lastname: Gougos
authors.affiliation: b Hematology-Oncology, Hospital for Sick Childrenj and Departments of Immunology and Pediatrics, University of Toronto, Toronto, Canada, M5G 1X8.
authors.forename: E J
authors.initials: EJ
authors.lastname: Quackenbush
authors.affiliation: c Division of Basic Sciences and Raymond and Beverley Sackler Foundation Laboratory, National Jewish Center for Immunology and Respiratory Medicine, Denver, CO, 80206, USA.
authors.forename: M H
authors.initials: MH
authors.lastname: Freedman
authors.affiliation: a Divisions of Immunology Hospital for Sick Childrenj and Departments of Immunology and Pediatrics, University of Toronto, Toronto, Canada, M5G 1X8.
authors.forename: E W
authors.initials: EW
authors.lastname: Gelfand
authors.affiliation: a Divisions of Immunology Hospital for Sick Childrenj and Departments of Immunology and Pediatrics, University of Toronto, Toronto, Canada, M5G 1X8.
authors.forename: M
authors.initials: M
authors.lastname: Letarte
keywords: ALL; Leukemia; antigens; phenotype